Name: Asgard’s CEO on the EUR 30 million Series A financing
Uploaded: 2024-03-22T11:11:34+01:00
Channel: Michael Jewett
Description: Asgard Therapeutics has recently announced a € 30 million Series A financing to advance its cell reprogramming platform for immuno-oncology.

Cristiana Pires, CEO Asgard Therapeutics

Asgard’s CEO on the EUR 30 million Series A financing

22 mars, 2024

Nyhetssvepet fredag 21 mars

21 mars, 2025

Tag: Asgard cell therapy

Asgard’s CEO on the EUR 30 million Series A financing

Nyhetssvepet fredag 21 mars